356 related articles for article (PubMed ID: 1379384)
21. Anticoagulation in patients with heparin-induced thrombocytopenia type II.
Harenberg J; Huhle G; Piazolo L; Wang LU; Heene DL
Semin Thromb Hemost; 1997; 23(2):189-96. PubMed ID: 9200346
[TBL] [Abstract][Full Text] [Related]
22. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.
Chong BH; Ismail F; Cade J; Gallus AS; Gordon S; Chesterman CN
Blood; 1989 May; 73(6):1592-6. PubMed ID: 2713496
[TBL] [Abstract][Full Text] [Related]
23. [Heparin-associated thrombocytopenia: successful therapy of patients after prospective selection of a compatible heparinoid with the heparin-induced platelet activation test].
Greinacher A; Michels I; Mueller-Eckhardt C
Beitr Infusionsther; 1992; 30():408-12. PubMed ID: 1284747
[TBL] [Abstract][Full Text] [Related]
24. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Lindhoff-Last E; Bauersachs R
Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
[TBL] [Abstract][Full Text] [Related]
25. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
26. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
Meuleman DG
Semin Thromb Hemost; 1989 Oct; 15(4):370-2. PubMed ID: 2479103
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
Frei U; Wilks MF; Boehmer S; Crisp-Lindgren N; Schwarzrock R; Stiekema JC; Koch KM
Nephrol Dial Transplant; 1988; 3(4):435-9. PubMed ID: 2459635
[TBL] [Abstract][Full Text] [Related]
28. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
[TBL] [Abstract][Full Text] [Related]
29. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
Hill GR; Hickton C; Henderson S; Patton WN
Clin Lab Haematol; 1997 Jun; 19(2):155-7. PubMed ID: 9218159
[TBL] [Abstract][Full Text] [Related]
30. [Heparin-induced thrombopenia and thrombosis].
Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
[TBL] [Abstract][Full Text] [Related]
31. Heparin-related thrombosis despite normal platelet counts in vascular surgery.
Hach-Wunderle V; Kainer K; Salzmann G; Müller-Berghaus G; Pötzsch B
Am J Surg; 1997 Feb; 173(2):117-9. PubMed ID: 9074376
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
[TBL] [Abstract][Full Text] [Related]
33. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
Hale LP; Smith K; Braden GA; Owen J
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897
[TBL] [Abstract][Full Text] [Related]
34. [Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].
Bredlich RO; Stracke S; Gall H; Proebstle TM
Dtsch Med Wochenschr; 1997 Mar; 122(11):328-32. PubMed ID: 9102281
[TBL] [Abstract][Full Text] [Related]
35. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
[TBL] [Abstract][Full Text] [Related]
36. [Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation].
Scheffler E; Aulmann M; Remppis A; Ziegler R; Martin E; Fleischer F; Nawroth P
Z Kardiol; 1995 Jul; 84(7):565-8. PubMed ID: 7676727
[TBL] [Abstract][Full Text] [Related]
37. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
[TBL] [Abstract][Full Text] [Related]
38. A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
Meuleman DG; Hobbelen PM; van Dedem G; Moelker HC
Thromb Res; 1982 Aug; 27(3):353-63. PubMed ID: 6182627
[TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
Gerhart TN; Yett HS; Robertson LK; Lee MA; Smith M; Salzman EW
J Bone Joint Surg Am; 1991 Apr; 73(4):494-502. PubMed ID: 1707413
[TBL] [Abstract][Full Text] [Related]
40. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease.
Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Wakeling A; Dandona P
Eur J Clin Invest; 1985 Dec; 15(6):313-9. PubMed ID: 3938401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
